Results 241 to 250 of about 131,135 (260)

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets

Cell Metabolism, 2021
Fan Bai, Yunsong Yang, Zhiming Shao
exaly  

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer

Cell, 2021
, Fabio Stossi, Lukas Simon
exaly  

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook

Pharmaceutics, 2023
Gantumur Battogtokh, Emmanuel Akala, Onyinyechi Obidiro   +2 more
exaly  

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy

Cell Metabolism, 2023
exaly  

Pembrolizumab for Early Triple-Negative Breast Cancer

New England Journal of Medicine, 2020
Cortes J, Theodoros Foukakis, Sherko Kuemmel   +2 more
exaly  

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Cell, 2018
Theodoros Foukakis, Nicholas Navin, Nicola Crosetto   +2 more
exaly  

Chemoimmunotherapy for Triple-Negative Breast Cancer

JAMA, 2018
openaire   +2 more sources

Triple-negative breast cancer: disease entity or title of convenience?

Nature Reviews Clinical Oncology, 2010
Luca Gianni, David Cameron, Eric Winer   +2 more
exaly  

Platinum-based chemotherapy in triple-negative breast cancer

Annals of Oncology, 2008
Sanjay Popat, B Sirohi, G Walsh
exaly  

Pembrolizumab for triple-negative breast cancer

The Lancet Oncology, 2020
openaire   +2 more sources